1
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
2
|
Suetsugu A, Nagaki M, Aoki H, Motohashi T,
Kunisada T and Moriwaki H: Characterization of CD133+
hepatocellular carcinoma cells as cancer stem/progenitor cells.
Biochem Biophys Res Commun. 351:820–824. 2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Setoguchi T, Taga T and Kondo T: Cancer
stem cells persist in many cancer cell lines. Cell cycle.
3:414–415. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Feuring-Buske M and Hogge DE: Hoechst
33342 efflux identifies a subpopulation of cytogenetically normal
CD34(+)CD38(−) progenitor cells from patients with acute myeloid
leukemia. Blood. 97:3882–3889. 2001.PubMed/NCBI
|
7
|
Uchida N, Fujisaki T, Eaves AC and Eaves
CJ: Transplantable hematopoietic stem cells in human fetal liver
have a CD34(+) side population (SP)phenotype. J Clini Invest.
108:1071–1077. 2001. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zen Y, Fujii T, Yoshikawa S, Takamura H,
Tani T, Ohta T and Nakanuma Y: Histological and culture studies
with respect to ABCG2 expression support the existence of a cancer
cell hierarchy in human hepatocellular carcinoma. Am J Pathol.
170:1750–1762. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hu C, Li H, Li J, Zhu Z, Yin S, Hao X, Yao
M, Zheng S and Gu J: Analysis of ABCG2 expression and side
population identifies intrinsic drug efflux in the HCC cell line
MHCC-97L and its modulation by Akt signaling. Carcinogenesis.
29:2289–2297. 2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Yan F, Wang XM, Liu ZC, Pan C, Yuan SB and
Ma QM: JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated
multidrug resistance of hepatocellular carcinoma cells.
Hepatobiliary Pancreat Dis Int. 9:287–295. 2010.PubMed/NCBI
|
13
|
Sancho R, Nateri AS, de Vinuesa AG,
Aguilera C, Nye E, Spencer-Dene B and Behrens A: JNK signalling
modulates intestinal homeostasis and tumourigenesis in mice. EMBO
J. 28:1843–1854. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Lu S, Shen KC, Wang Y, Brooks SC and Wang
YA: Impaired hepatocyte survival and liver regeneration in
Atm-deficient mice. Hum Mol Genet. 14:3019–3025. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Komoda F, Shino Y, Hirano T, Okutomi Y,
Okamoto H, Hayashi Y, Suyama T, Ebara M, Saisho H and Shirasawa H:
MEKK1 induces c-Jun complexes that act as negative regulators for
cell survival and proliferation of HCC cells. Int J Oncol.
21:553–559. 2002.PubMed/NCBI
|
16
|
Goodell MA: Multipotential stem cells and
‘side population’ cells. Cytotherapy. 4:507–508. 2002.
|
17
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Sharma SV, Lee DY, Li B, Quinlan MP,
Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach
MA, Wong KK, Brandstetter K, Wittner B, Ramaswamy S, Classon M and
Settleman J: A chromatin-mediated reversible drug-tolerant state in
cancer cell subpopulations. Cell. 141:69–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yoon CH, Kim MJ, Kim RK, Lim EJ, Choi KS,
An S, Hwang SG, Kang SG, Suh Y, Park MJ and Lee SJ: c-Jun
N-terminal kinase has a pivotal role in the maintenance of
self-renewal and tumorigenicity in glioma stem-like cells.
Oncogene. 31:4655–4666. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Nagata H, Hatano E, Tada M, Murata M,
Kitamura K, Asechi H, Narita M, Yanagida A, Tamaki N, Yagi S, Ikai
I, Matsuzaki K and Uemoto S: Inhibition of c-Jun NH2-terminal
kinase switches Smad3 signaling from oncogenesis to tumor-
suppression in rat hepatocellular carcinoma. Hepatology.
49:1944–1953. 2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Mucha SR, Rizzani A, Gerbes AL, Camaj P,
Thasler WE, Bruns CJ, Eichhorst ST, Gallmeier E, Kolligs FT, Goke B
and De Toni EN: JNK inhibition sensitises hepatocellular carcinoma
cells but not normal hepatocytes to the TNF-related
apoptosis-inducing ligand. Gut. 58:688–698. 2009. View Article : Google Scholar
|
22
|
Seki E, Brenner DA and Karin M: A liver
full of JNK: signaling in regulation of cell function and disease
pathogenesis, and clinical approaches. Gastroenterology.
143:307–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Zhang DM, Shu C, Chen JJ, Sodani K, Wang
J, Bhatnagar J, Lan P, Ruan ZX, Xiao ZJ, Ambudkar SV, Chen WM, Chen
ZS and Ye WC: BBA, a derivative of 23-hydroxybetulinic acid,
potently reverses ABCB1-mediated drug resistance in vitro and in
vivo. Mol Pharm. 9:3147–3159. 2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Hagiwara S, Kudo M, Chung H, Ueshima K,
Inoue T, Haji S, Watanabe T, Park AM, Munakata H and Sakurai T:
2012. Activation of c-Jun N-terminal kinase in non-cancerous liver
tissue predicts a high risk of recurrence after hepatic resection
for hepatocellular carcinoma. Hepatol Res. 42:394–400. 2012.
View Article : Google Scholar
|